The Secret "Spice'': An Undetectable Toxic Cause of Seizure

被引:28
作者
de Havenon, Adam [1 ]
Chin, Brian [2 ]
Thomas, Karen C. [3 ]
Afra, Pegah [1 ]
机构
[1] Univ Utah, Sch Med, Dept Neurol, 175 N Med Dr East, Salt Lake City, UT 84132 USA
[2] Univ Utah, Sch Med, Dept Radiol, Salt Lake City, UT USA
[3] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT 84112 USA
关键词
Spice; synthetic cannabinoid; cannabis toxicity; marijuana toxicity; first generalized seizure; provoked seizure; toxic seizure;
D O I
10.1177/1941874411417977
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurologists and emergency department physicians are frequently involved in the comprehensive evaluation of a first generalized seizure. An important aspect of this evaluation is a detailed history which can identify a provoked seizure secondary to drug toxicity and hence avoid unnecessary treatment with antiepileptic drugs. "Spice'' is an umbrella term for a variety of synthetic cannabinoid products whose inhalation has been associated with an increasing number of toxic side effects resulting in emergency department visits. These side effects (including psychosis, tachyarrhythmia, and seizures) are not typically seen with marijuana (Cannabis sativa) use. We report 2 patients with no prior history of neurological disease that experienced their first generalized tonic-clonic seizure after smoking Spice. The mechanism behind the possible proconvulsant effect of synthetic cannabinoids is not known, but it may be due to their effects at the cannabinoid receptor CB1. Although the US Drug Enforcement Administration placed 5 synthetic cannabinoids into schedule 1 for a 12-month period beginning March 2011, new Spice products containing different synthetic cannabinoids continue to emerge. Because synthetic cannabinoids are not detectable on commercial drug screens it is important that neurologists and emergency department physicians consider Spice inhalation in their differential diagnosis of a first generalized seizure.
引用
收藏
页码:182 / 186
页数:5
相关论文
共 18 条
[1]   An introduction to the endocannabinoid system: from the early to the latest concepts [J].
De Petrocellis, Luciano ;
Di Marzo, Vincenzo .
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 23 (01) :1-15
[2]   Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples [J].
Dresen, Sebastian ;
Kneisel, Stefan ;
Weinmann, Wolfgang ;
Zimmermann, Ralf ;
Auwaerter, Volker .
JOURNAL OF MASS SPECTROMETRY, 2011, 46 (02) :163-171
[3]  
Grinspoon L, 1997, MARIHUANA FORBIDDEN, P66
[4]   Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus [J].
Hájos, N ;
Ledent, C ;
Freund, TF .
NEUROSCIENCE, 2001, 106 (01) :1-4
[5]   First seizure definitions and worldwide incidence and mortality [J].
Hauser, W. Allen ;
Beghi, Ettore .
EPILEPSIA, 2008, 49 :8-12
[6]   Is a first acute symptomatic seizure epilepsy? Mortality and risk for recurrent seizure [J].
Hesdorffer, Dale C. ;
Benn, Emma K. T. ;
Cascino, Gregory D. ;
Hauser, W. Allen .
EPILEPSIA, 2009, 50 (05) :1102-1108
[7]  
Hudson S, 2011, DRUG TEST ANAL
[8]   Newly diagnosed unprovoked epileptic seizures: Presentation at diagnosis in CAROLE study [J].
Jallon, P ;
Loiseau, P ;
Loiseau, J .
EPILEPSIA, 2001, 42 (04) :464-475
[9]   Cannabidiol Displays Antiepileptiform and Antiseizure Properties In Vitro and In Vivo [J].
Jones, Nicholas A. ;
Hill, Andrew J. ;
Smith, Imogen ;
Bevan, Sarah A. ;
Williams, Claire M. ;
Whalley, Benjamin J. ;
Stephens, Gary J. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 332 (02) :569-577
[10]   Spice: A never ending story? [J].
Lindigkeit, Rainer ;
Boehme, Anja ;
Eiserloh, Ina ;
Luebbecke, Maike ;
Wiggermann, Marion ;
Ernst, Ludger ;
Beuerle, Till .
FORENSIC SCIENCE INTERNATIONAL, 2009, 191 (1-3) :58-63